"Melanoma" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A malignant neoplasm derived from cells that are capable of forming melanin, which may occur in the skin of any part of the body, in the eye, or, rarely, in the mucous membranes of the genitalia, anus, oral cavity, or other sites. It occurs mostly in adults and may originate de novo or from a pigmented nevus or malignant lentigo. Melanomas frequently metastasize widely, and the regional lymph nodes, liver, lungs, and brain are likely to be involved. The incidence of malignant skin melanomas is rising rapidly in all parts of the world. (Stedman, 25th ed; from Rook et al., Textbook of Dermatology, 4th ed, p2445)
| Descriptor ID |
D008545
|
| MeSH Number(s) |
C04.557.465.625.650.510 C04.557.580.625.650.510 C04.557.665.510
|
| Concept/Terms |
Melanoma- Melanoma
- Melanomas
- Malignant Melanoma
- Malignant Melanomas
- Melanoma, Malignant
- Melanomas, Malignant
|
Below are MeSH descriptors whose meaning is more general than "Melanoma".
Below are MeSH descriptors whose meaning is more specific than "Melanoma".
This graph shows the total number of publications written about "Melanoma" by people in this website by year, and whether "Melanoma" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 11 | 0 | 11 |
| 1997 | 8 | 0 | 8 |
| 1998 | 10 | 0 | 10 |
| 1999 | 9 | 0 | 9 |
| 2000 | 14 | 1 | 15 |
| 2001 | 13 | 3 | 16 |
| 2002 | 16 | 3 | 19 |
| 2003 | 14 | 2 | 16 |
| 2004 | 14 | 2 | 16 |
| 2005 | 16 | 2 | 18 |
| 2006 | 29 | 2 | 31 |
| 2007 | 21 | 1 | 22 |
| 2008 | 26 | 3 | 29 |
| 2009 | 29 | 2 | 31 |
| 2010 | 24 | 5 | 29 |
| 2011 | 38 | 3 | 41 |
| 2012 | 33 | 3 | 36 |
| 2013 | 34 | 5 | 39 |
| 2014 | 37 | 5 | 42 |
| 2015 | 34 | 0 | 34 |
| 2016 | 23 | 0 | 23 |
| 2017 | 51 | 1 | 52 |
| 2018 | 27 | 1 | 28 |
| 2019 | 41 | 0 | 41 |
| 2020 | 32 | 5 | 37 |
| 2021 | 26 | 1 | 27 |
| 2022 | 31 | 0 | 31 |
| 2023 | 34 | 0 | 34 |
| 2024 | 24 | 5 | 29 |
| 2025 | 16 | 1 | 17 |
| 2026 | 12 | 2 | 14 |
To return to the timeline,
click here.
Below are the most recent publications written about "Melanoma" by people in Profiles.
-
Years of life lost in patients with a false-negative diagnosis of primary melanoma. A prospective study of the German Central Malignant Melanoma Registry involving 9063 patients over 28 years. Nat Commun. 2026 07 02; 17(1).
-
Durable stable disease and immune activation in metastatic uveal melanoma treated with tebentafusp: case report. Front Immunol. 2026; 17:1864115.
-
Prevalence of Familial Melanoma Genes and Cancer Risk Among Genomically Ascertained Individuals. JAMA Dermatol. 2026 07 01; 162(7):692-700.
-
CHOROIDAL MELANOMA ARISING FROM OPTIC DISK MELANOCYTOMA WITH ASSOCIATED PATHOLOGY AND GENETIC FINDINGS CASE REPORT. Retin Cases Brief Rep. 2026 Jul 01; 20(4):488-492.
-
Personalized targeting of BCL2 family proteins overcomes acquired resistance to BRAF-MEK inhibitors in preclinical melanoma. Nat Commun. 2026 Jun 26; 17(1).
-
Purinergic activity of circulating extracellular vesicles associates with disease progression in melanoma. Oncoimmunology. 2026 Dec 31; 15(1):2688603.
-
Predicting immune-related thyroiditis using polygenic risk scores in patients with advanced melanoma. J Immunother Cancer. 2026 Jun 19; 14(6).
-
Impact of GM-CSF and Two-Site Vaccination on Clinical Outcomes after Multipeptide Vaccination for Melanoma: Long-term Analysis of a Randomized Phase II Trial. Clin Cancer Res. 2026 Jun 15; 32(12):2381-2390.
-
Pregnancy Outcomes After in Utero Exposure to Immune Checkpoint Inhibitors. Curr Oncol. 2026 May 28; 33(6).
-
Discontinuation of combo immunotherapy and outcome of patients with melanoma brain metastases. J Immunother Cancer. 2026 May 04; 14(5).